Brent Kennedy is a Manager in the Biologics department at Catalent. Brent leads a team of Scientists and has an extensive background in Biophysical and Biochemical characterization of large molecule therapeutics in particular SEC-MALS and SV-AUC. He holds a BA in Cell Biology from the University of Northern Colorado and has 24+ years of biopharmaceutical experience in the Analytical Chemistry sphere.